Pasithea Therapeutics Corp.

KTTA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$3-$4-$4-$3
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$0-$0$0$0
Other Non-Cash$0$0$0$0
Operating Cash Flow-$3-$4-$3-$2
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.-$0-$0-$0$0
Stock Issued$0$6$2-$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow-$0$6$1-$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$3$2-$2-$2
Supplemental Information
Beg. Cash$7$5$7$9
End Cash$4$7$5$7
Free Cash Flow-$3-$4-$3-$2
Pasithea Therapeutics Corp. (KTTA) Financial Statements & Key Stats | AlphaPilot